SOLUCAPS 2MG MAZINDOL 30 CAPSULES

Description

SOLUCAPS 2MG MAZINDOL 30 CAPSULES

 

Solucaps 2mg Mazindol  is formulated to help people lose weight quickly and with a short treatment, in a complementary way to a hypocaloric diet. Madinzol is an anorectic sold in Mexico, which decreases appetite among other useful effects to combat obesity.

Solucaps Mazindol should not be administered to patients with advanced arteriosclerosis, symptomatic cardiovascular disease, severe arterial hypertension, hyperthyroidism, hypersensitivity or idiosyncrasy to sympathometric amines, glaucoma, agitation states, history of drug addiction, severe heart and kidney failure, arrhythmia.

CONTRAINDICATION

Solucaps Mazindol should not be administered to patients with advanced arteriosclerosis, symptomatic cardiovascular disease, severe arterial hypertension, hyperthyroidism, hypersensitivity or idiosyncrasy to sympathometric amines, glaucoma, agitation states, history of drug addiction, severe heart and kidney failure, arrhythmia. Along with ganglionic or neural blockers or with MAO inhibitors. In pregnancy or lactation.

Precautions

Solucaps Mazindol 2mg is recommended not to interrupt the treatment abruptly, unless the presence of an adverse effect requires it. Given its presentation in capsules, it is possible to establish an alternating regimen of administration every 3rd, 4th or 5th day, until the interruption, which must be adapted to each patient. During the treatment period, patients should be advised of the possibility of a decrease in reflexes while operating dangerous machinery or driving a car. Patients should be advised of the use of local anesthetics for dental procedures, they should consult their doctor first. Patients should be warned not to open or chew the capsules; they must be swallowed to preserve the granule protection layer.

Possible side effects

There may be palpitations, tachycardia, arrhythmia, hypertension, dizziness, nervousness, restlessness, insomnia, weakness or fatigue, agitation, headache, dry mouth, nausea, vomiting, constipation, rash, erythema, eye irritation, mydriasis, dysuria, polyuria and menstrual disorders.

Drug interactions

The concomitant administration of Solucaps Mazindol 2mg and antihypertensive drugs of the neural blocking type such as guanethidine is contraindicated. It should not be administered during treatment with MAO inhibitors, it should be expected at least 14 days after the last administration of these.

Alterations in blood, serum or urine values ​​are not clinically significant when they occur at therapeutic doses. Solucaps Mazindol 2mg moderately lowers blood glucose levels, independently of appetite suppressant effects, by increasing glucose in human skeletal muscle.

Precautions in relation to effects of carcinogenesis, mutagenesis, teratogenesis and on fertility:

No carcinogenic, mutagenic, teratogenic or fertility effects have been reported. The use of this product requires strict medical control.

Dosage

Oral. 1 capsule after breakfast.

overdosage

The minimum lethal dose in humans is unknown. It has been reported a case of ingestion for suicide purposes of 80 mg of mazindol to which the patient survived. Another patient died due to an intake of 200 mg. Some cases in pediatrics (1-4 years) with survival have been reported with doses of 20 and 40 mg. Mazindol, due to its acid nature, does not respond to dialysis with neutral or alkaline products. Symptoms: tremor, hyperreflexia, rapid breathing, hyperpyrexia, tachypnea, vertigo, confusion, hallucinations, panic states. Depression and fatigue, usually follows the central stimulation tachycardia, hypertension or hypotension, circulatory collapse, nausea, vomiting, diarrhea, abdominal colic. Treatment: maintenance of airways and permeable vascular, control and surveillance of vital signs. Forced acid diuresis. A hemodialysis may be indicated. The use of sympatholytics can counteract or abolish sympathetic intoxication.

 

Buy Asenlix 30mg click here